Papoutsanis S.A (PAP)
Athens Exchange · Greece · prices in EUR · close of 22 Oct 2026
Key indicators
| Last close | EUR 3.360 |
|---|---|
| 52-week range | 2.790 – 4.060 |
| Return, 1 month / 3 months | +0.3% / −6.4% |
| Return, 1 year / 3 years | +10.9% / +68.9% |
| Trend | Below its 200-day average |
| RSI (14) | 44 |
| Volatility (1 year) | 30.1% |
| Worst drawdown (1 year) | -19.8% |
| Average daily value traded | 0.07M EUR |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Papoutsanis is a Greek maker of soaps and personal care products based in Athens. The company produces bar soap, liquid soap and related cleansing items, and it makes goods under its own brands as well as for retailers who put their own labels on them. Its customers include supermarkets, retailers and distributors in Greece and in export markets, and the business also supplies soap products for hospitality and professional use.
On this site Papoutsanis S.A appears as a stock on the Athens Exchange (Greece), code PAP, with prices in euros (EUR). Our dividend records, which start in 2019, show payments in 5 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Papoutsanis S.A (PAP) trades on the Athens Exchange in Greece. It last closed at EUR 3.360 on 22 October 2026.
Its price-based Market X-Ray is 48 out of 100 (a weak price profile), ranking 81 of 143 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 10.9% and over the last three months it fell 6.4%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Athens Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 42 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -5.3% | ||
| From 52-week high | -15.8% | ||
| Momentum | 37 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -6.4% | ||
| 6-month return | -10.4% | ||
| 12-month return, skipping the last month | 10.6% | ||
| Stability (higher is calmer) | 63 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 30.1% | ||
| Worst drawdown, 1 year (smaller is calmer) | -19.8% | ||
| Liquidity | 52 · Fair | Moderate trading activity. | |
| Average daily value traded | 0.07M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 3 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
Returns
| 1 week | −1.5% |
|---|---|
| 1 month | +0.3% |
| 3 months | −6.4% |
| 6 months | −10.4% |
| 1 year | +10.9% |
| 3 years | +68.9% |
| 5 years | +68.4% |
Signals
| 50-day / 200-day average | 3.414 / 3.548 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.070 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 22 May 2023 | EUR 0.0200 |
| 5 Dec 2022 | EUR 0.0201 |
| 21 Apr 2022 | EUR 0.0500 |
| 27 Oct 2021 | EUR 0.0200 |
| 7 May 2021 | EUR 0.0500 |
| 8 Sep 2020 | EUR 0.0200 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Athens Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.